Keywords: evotec, enters, 3-year, deal, novartis, germany, started
Evotec enters 3-year deal with Novartis
Article | 08 December 2008
Germany's Evotec has started a three-year research collaboration with Swiss drug major Novartis to identify and develop novel small-molecule therapeutics.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
